摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-((3-methoxyphenyl)sulfonyl)-6-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydroquinoline

中文名称
——
中文别名
——
英文名称
1-((3-methoxyphenyl)sulfonyl)-6-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydroquinoline
英文别名
1-(3-methoxyphenyl)sulfonyl-6-(pyridin-3-ylmethyl)-3,4-dihydro-2H-quinoline
1-((3-methoxyphenyl)sulfonyl)-6-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydroquinoline化学式
CAS
——
化学式
C22H22N2O3S
mdl
——
分子量
394.494
InChiKey
AOWCXLCQYCLKFT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    28
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    67.9
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    3-甲氧基苯磺酰氯 、 6-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydroquinoline 在 吡啶4-二甲氨基吡啶 作用下, 以 四氢呋喃 为溶剂, 以72%的产率得到1-((3-methoxyphenyl)sulfonyl)-6-(pyridin-3-ylmethyl)-1,2,3,4-tetrahydroquinoline
    参考文献:
    名称:
    Potent 11β-Hydroxylase Inhibitors with Inverse Metabolic Stability in Human Plasma and Hepatic S9 Fractions To Promote Wound Healing
    摘要:
    Topical application of CYP11B1 inhibitors to reduce cutaneous cortisol is a novel strategy to promote healing of chronic wounds. Pyridyl substituted arylsulfonyltetrahydroquinolines were designed and synthesized resulting in a strong inhibitor 34 (IC50 = S nM). It showed no inhibition of CYP17 and CYP19 and no mutagenic effects. It exhibited inverse metabolic stability in plasma (t(1/2) >> 150 mm), which is similar to wound fluid in composition, and in liver S9 fractions (t(1/2) = 16 mm).
    DOI:
    10.1021/jm501004t
点击查看最新优质反应信息

文献信息

  • Potent 11β-Hydroxylase Inhibitors with Inverse Metabolic Stability in Human Plasma and Hepatic S9 Fractions To Promote Wound Healing
    作者:Weixing Zhu、Qingzhong Hu、Nina Hanke、Chris J. van Koppen、Rolf W. Hartmann
    DOI:10.1021/jm501004t
    日期:2014.9.25
    Topical application of CYP11B1 inhibitors to reduce cutaneous cortisol is a novel strategy to promote healing of chronic wounds. Pyridyl substituted arylsulfonyltetrahydroquinolines were designed and synthesized resulting in a strong inhibitor 34 (IC50 = S nM). It showed no inhibition of CYP17 and CYP19 and no mutagenic effects. It exhibited inverse metabolic stability in plasma (t(1/2) >> 150 mm), which is similar to wound fluid in composition, and in liver S9 fractions (t(1/2) = 16 mm).
查看更多